WASHINGTON, Oct 24 (Reuters) - A warning is being added to Cephalon Inc’s (CEPH.O: Quote, Profile, Research) drug Provigil for excessive sleepiness because of the risk of serious skin rash and psychiatric symptoms, the U.S. Food and Drug Administration said on Wednesday.
